Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × sintilimab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 6 Stomach Neoplasms 3 Colorectal Neoplasms 3 Neoplasm Metastasis 2 Triple Negative Breast Neoplasms 1 Spinocerebellar Degenerations 1 Resectable NSCLC 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma 1

Interventions

Cyclophosphamide 8 Rituximab 7 Specimen Handling 5 obinutuzumab 4 fludarabine 4 Magnetic Resonance Spectroscopy 4 tazemetostat 3 polatuzumab vedotin 3 pirtobrutinib 3 Vincristine 3 Prednisone 3 Nivolumab 3 Doxorubicin 3 zanubrutinib 2 ibrutinib 2 glofitamab 2 acalabrutinib 2 Biopsy 2 venetoclax 1 tafasitamab 1 sodium-iodide symporter 1 ruxolitinib 1 pomalidomide 1 pembrolizumab 1 palbociclib 1 iberdomide 1 etoposide phosphate 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 brexucabtagene autoleucel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡